GOSH researchers use technology to engineer donor T-cells for children with resistant leukaemia

Researchers at Great Ormond Street Hospital for Children (GOSH) and UCL Great Ormond Street Institute of Child Health (UCL GOSH ICH) have used new technology to engineer T-cells to treat seriously ill children. The first phase of the trial, published in Science Translational Medicine, is said to be “the first … Continue reading GOSH researchers use technology to engineer donor T-cells for children with resistant leukaemia